Evidence map›Paper›PMID 41300715›Full record

ReviewGenes2025

The Enhancement of Fungal Disease Resistance in Major Staple Crops Using CRISPR-Cas Technology.

Zagipa Sapakhova, Rakhim Kanat, Dias Daurov, Ainash Daurova, Malika Shamekova, Kabyl Zhambakin

Abstract readReview
In one paragraph

Review in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zagipa SapakhovaInstitute of Plant Biology and Biotechnology, Almaty 050040, Kazakhstan.ORCID 0000-0002-8007-5066
Rakhim KanatInstitute of Plant Biology and Biotechnology, Almaty 050040, Kazakhstan.ORCID 0009-0009-2418-5920
Dias DaurovInstitute of Plant Biology and Biotechnology, Almaty 050040, Kazakhstan.ORCID 0000-0003-3073-4577
Ainash DaurovaInstitute of Plant Biology and Biotechnology, Almaty 050040, Kazakhstan.ORCID 0000-0001-7949-9112
Malika ShamekovaInstitute of Plant Biology and Biotechnology, Almaty 050040, Kazakhstan.ORCID 0000-0002-8746-7484
Kabyl ZhambakinInstitute of Plant Biology and Biotechnology, Almaty 050040, Kazakhstan.ORCID 0000-0001-5243-145X

Funding

Ministry of Science and Higher Education of the Republic of Kazakhstan BR21882269
6 · The paper itself

Abstract

Fungal pathogens represent a major constraint to global agricultural productivity, causing a wide range of plant diseases that severely affect staple crops such as cereals, legumes, and vegetables. These infections result in substantial yield losses, deterioration of grain and produce quality, and significant economic impacts across the entire agri-food sector. Among phytopathogens, fungi are considered the most destructive, causing a wide range of diseases such as powdery mildew, rusts, fusarium head blight, smut, leaf spot, rots, late blight, and other fungal pathogens. Traditional plant protection methods do not always provide long-term effectiveness and environmental safety, which requires the introduction of innovative approaches to creating sustainable varieties. CRISPR-Cas technology opens up new opportunities for targeted genome editing, allowing the modification or silencing of susceptibility genes and thus increasing plant resistance to fungal infections. This review presents current achievements and prospects for the application of CRISPR-Cas technology to increase the resistance of major agricultural crops to fungal diseases. The implementation of these approaches contributes to the creation of highly productive and resistant varieties, which is crucial for ensuring food security in the context of climate change.

Indexed as

CRISPR-Cas SystemsCrops, AgriculturalDisease ResistancePlant DiseasesFungiGene EditingPlants, Genetically ModifiedcerealsCRISPR-Casfungal diseaseslegumesmain agricultural cropsvegetables

Identifiers

PMID41300715
PMCPMC12652551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.